InsidersTradesSigma
Declaraciones totales
Empresa
▲ Compras (0 oper.)
▼ Ventas (50 oper.)
Historial del iniciado
Director GeneralCompras declaradas
0
Ventas declaradas
50
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Explore the complete record of transactions filed by Saxonov Serge, Chief Executive Officer. Insider active across 1 company, notably 10x Genomics, Inc.. Cumulatively, 87 filings have been published. Split: 0 buy · 50 sells. Total volume traded: €5.9m. History available since 4 May 2021. The latest transaction was disclosed on 1 September 2026 (Don). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Saxonov Serge
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones87 en total
100 títulos0Class A Common StockSEC:0001610717-26-000396:0
3500 títulos@ 63,0229 US$0.0026% mcap2.5% de su flujoClass A Common StockSEC:0001610717-26-000393:0
6494 títulos@ 63,9768 US$0.0049% mcap4.8% de su flujoClass A Common StockSEC:0001610717-26-000393:1
492 títulos@ 64,7465 US$0.0004% mcap0.4% de su flujoClass A Common StockSEC:0001610717-26-000393:2
18.545 títulos@ 63,0237 US$0.014% mcap14.5% de su flujoClass A Common StockSEC:0001610717-26-000392:0
4000 títulos0Class A Common StockSEC:0001610717-26-000386:0
8527 títulosClass A Common StockSEC:0001610717-26-000293:0
9991 títulosClass A Common StockSEC:0001610717-26-000293:1
9821 títulosClass A Common StockSEC:0001610717-26-000293:2
1661 títulosClass A Common StockSEC:0001610717-26-000293:3
18.175 títulos@ 24,4415 US$0.0059% mcap8.4% de su flujoClass A Common StockSEC:0001610717-26-000164:0
10.718 títulos@ 24,7092 US$0.0035% mcap5.0% de su flujoClass A Common StockSEC:0001610717-26-000164:1
5000 títulos@ 24,5568 US$0.0016% mcap2.2% de su flujoClass A Common StockSEC:0001610717-26-000145:0
10.000 títulos@ 19,1297 US$3.8% de su flujoClass A Common StockSEC:0001610717-26-000134:0
14.292 títulos@ 22,669 US$5.6% de su flujoClass A Common StockSEC:0001610717-26-000086:0
157.895 títulos0Class A Common StockSEC:0001610717-26-000077:0
9632 títulos@ 18,5764 US$3.1% de su flujoClass A Common StockSEC:0001610717-26-000070:0
50.000 títulos@ 1,20 US$1.1% de su flujoClass A Common StockSEC:0001610717-26-000003:0
13.261 títulos@ 18,9983 US$4.8% de su flujoClass A Common StockSEC:0001610717-25-000398:0
900 títulos0Class A Common StockSEC:0001610717-25-000341:0
9348 títulos@ 13,787 US$2.4% de su flujoClass A Common StockSEC:0001610717-25-000321:0
1000 títulos0Class A Common StockSEC:0001610717-25-000199:0
3000 títulos0Class A Common StockSEC:0001610717-25-000147:0
9343 títulos@ 8,2993 US$1.5% de su flujoClass A Common StockSEC:0001610717-25-000144:0
171.428 títulos0Class A Common StockSEC:0001610717-25-000075:0
25 de 87 declaraciones
About Saxonov Serge
Saxonov Serge is Chief Executive Officer at 10x Genomics, Inc. He has made 81 filings in total, and the 81 sampled filings, from 2021-05-05 to 2026-06-24, show only sales for a total of EUR 4376621, with the modal transaction nature listed as Cession.
